FMGE · blueprint and recall
FMGE Pharmacology
Seen in 19 of the 19 sessions with recall; 11 of the 11 well-covered sessions. Explore the chapters in this subject, then the topics and styles represented in the recall.
- Official questions
- 13
- NBEMS subject blueprint
- Concept cards
- 187
- unofficial recall collection
- Chapters
- 9
- Lumi's outline
- Outline topics seen
- 45
- of 49 in the outline
Official allocation and recall share
Pharmacology
Official: 13 questions
- Official share
- 4.3%
- Recall share, unofficial
- 6.2%
Recall share uses concept appearances across the well-covered sessions. A concept appearing in multiple sessions counts in each of them. It is not an official question distribution. Based on the 11 well-covered sessions. Percentages are shown to one decimal place.
Official source: NBEMS FMGE information bulletin, chapter 12. Chapter and topic groupings are Lumi's outline.
Chapters by recurrence
Ordered by sessions with recall, with well-covered recurrence alongside. Open a chapter for its full topic list.
Pharmacology
Chemotherapy
Seen in 17 of the 19 sessions with recall; 11 of the 11 well-covered sessions.
8 outline topics seen · 37 concepts
Pharmacology
Cardiovascular & Renal
Seen in 15 of the 19 sessions with recall; 10 of the 11 well-covered sessions.
5 outline topics seen · 25 concepts
Pharmacology
Central Nervous System
Seen in 14 of the 19 sessions with recall; 9 of the 11 well-covered sessions.
7 outline topics seen · 21 concepts
Pharmacology
Autonomic Nervous System
Seen in 13 of the 19 sessions with recall; 10 of the 11 well-covered sessions.
5 outline topics seen · 23 concepts
Pharmacology
Endocrine
Seen in 13 of the 19 sessions with recall; 9 of the 11 well-covered sessions.
5 outline topics seen · 20 concepts
Pharmacology
General Pharmacology
Seen in 11 of the 19 sessions with recall; 10 of the 11 well-covered sessions.
5 outline topics seen · 22 concepts
Pharmacology
Autacoids & Respiratory
Seen in 11 of the 19 sessions with recall; 10 of the 11 well-covered sessions.
4 outline topics seen · 18 concepts
Pharmacology
Blood & GIT
Seen in 10 of the 19 sessions with recall; 9 of the 11 well-covered sessions.
5 outline topics seen · 19 concepts
Pharmacology
Toxicology & Miscellaneous
Seen in 2 of the 19 sessions with recall; 1 of the 11 well-covered sessions.
1 outline topics seen · 2 concepts
Topics seen in the most sessions
The outline topics with the widest recurrence in this subject's unofficial recall.
Chemotherapy
Anticancer drugs
Seen in 14 of the 19 sessions with recall; 10 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jan 2026.
Styles: one-liner (10) · vignette (3).
Endocrine
Insulin and oral antidiabetics
Seen in 10 of the 19 sessions with recall; 8 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.
Styles: one-liner (8) · vignette (2).
Central Nervous System
Antiepileptics
Seen in 10 of the 19 sessions with recall; 7 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jan 2025.
Styles: one-liner (6) · vignette (2) · image + vignette (1).
Cardiovascular & Renal
Antihypertensives
Seen in 9 of the 19 sessions with recall; 7 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.
Styles: one-liner (5) · vignette (4) · image-ID (1).
Cardiovascular & Renal
Diuretics
Seen in 9 of the 19 sessions with recall; 6 of the 11 well-covered sessions.
First seen: FMGE Dec 2010. Last seen: FMGE Jan 2025.
Styles: one-liner (4) · vignette (3) · image + vignette (1) · image-ID (1).
Blood & GIT
Anticoagulants and antiplatelets
Seen in 8 of the 19 sessions with recall; 7 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.
Styles: one-liner (8) · vignette (2).
Autonomic Nervous System
Adrenergic blockers
Seen in 8 of the 19 sessions with recall; 6 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jan 2023.
Styles: one-liner (7) · vignette (2).
Autonomic Nervous System
Cholinergic drugs
Seen in 8 of the 19 sessions with recall; 6 of the 11 well-covered sessions.
First seen: FMGE Dec 2009. Last seen: FMGE Jan 2025.
Styles: one-liner (3) · vignette (2).
Autacoids & Respiratory
Drugs for asthma and cough
Seen in 6 of the 19 sessions with recall; 6 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.
Styles: one-liner (6) · vignette (2).
General Pharmacology
Pharmacodynamics
Seen in 6 of the 19 sessions with recall; 6 of the 11 well-covered sessions.
First seen: FMGE Dec 2018. Last seen: FMGE Jan 2023.
Styles: one-liner (5) · image-ID (2).
Chemotherapy
Antimalarials and anthelmintics
Seen in 6 of the 19 sessions with recall; 5 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.
Styles: one-liner (4) · vignette (1).
Autacoids & Respiratory
Drugs for gout and rheumatoid arthritis
Seen in 6 of the 19 sessions with recall; 5 of the 11 well-covered sessions.
First seen: FMGE Jun 2011. Last seen: FMGE Jan 2023.
Styles: one-liner (3) · vignette (2).
Question styles and image links
Question styles in the recall
- one-liner
- 132 concepts · 70.6%
- vignette
- 48 concepts · 25.7%
- image-ID
- 4 concepts · 2.1%
- image + vignette
- 3 concepts · 1.6%